Women's health Archives - Page 2 of 17

Women's health

Clinical Articles

The breast lump workup

While breast lumps are common, deciding what to do when someone presents with one can be tricky...

Expert/s: Sophia Auld

Women's health

Clinical Articles

MHT risks and progestogens

While the risks of unopposed oestrogen are widely acknowledged, important nuances can be missed...

Expert/s: Fiona Clark, Prof Rod Baber

Women's health

Clinical Articles

MHT & bone health: how does it stack up?

MHT can be just as effective for preventing postmenopausal fracture as bone-specific medications—minus some of the risks.

Expert/s: Sophia Auld

Women's health

Podcasts

Polycystic ovarian syndrome – Part 2: Clinical features

Dr Anju Joham & Dr Chau Thien (Jillian) Tay discuss the clinical features of PCOS diagnosis, inlcuding pregnancy and long-term health impacts.

Expert/s: Dr Anju Joham, Dr Chau Thien (Jillian) Tay

Obstetrics and gynaecology, Women's health

Clinical Articles

Ryeqo approved for endometriosis

Ryeqo has been available in Australia since 2022, but until now was not specifically indicated for endometriosis. Here's how it works and what you need to be aware of.

Expert/s: A/Prof Nial Wheate, Jasmine Lee

Women's health

Clinical Articles

Feminist narratives are being hijacked to market medical tests not backed by evidence

Corporations have used feminist language to promote their products for decades. In the 1980s, companies co-opted messaging about female autonomy to encourage women’s consumption of unhealthy commodities, such as tobacco and alcohol.

Expert/s: Dr Brooke Nickel, Tessa Copp

Women's health

Podcasts

Polycystic ovarian syndrome – Part 1: Diagnosis

Dr Anju Joham & Dr Chau Thien (Jillian) Tay discuss the clinical features with PCOS diagnosis and how this may differ across the lifespan, and clarity regarding PCOS and pregnancy.

Expert/s: Dr Anju Joham, Dr Chau Thien (Jillian) Tay

Women's health

Clinical Articles

New vaginal atrophy treatment coming soon

Intrarosa was approved by the TGA last year and is expected to be available in Australia from mid-2024. Here's what you need to know...

Expert/s: Sophia Auld

Women's health

Clinical Articles

Natural supplements for menopause – worth it or waste of money?

The market is awash with products claiming to be rooted in ancient traditions that have allegedly given women relief from menopausal symptoms - but how do the claims stack up?

Expert/s: Fiona Clark

Women's health

Clinical Articles

Hot flushes and night sweats: non-hormonal pharmacological options

We look at the evidence for pharmaceutical agents beyond MHT...

Expert/s: Fiona Clark

Oncology, Women's health

Clinical Articles

Cervical cancer screening podcast series

Prof Deborah Bateson, Sexual Health Physician, and Dr Rebecca South, Women's Health GP, answer a series of questions on the topic of cervical cancer screening. These questions were compiled by GPs and health professionals across Australia.

Expert/s: Healthed

Haematology, Neurology, Women's health

Clinical Articles

Top podcasts of 2023

We’ve compiled all the popular podcasts your colleagues have been listening to in 2023.

Expert/s: Healthed

Women's health

The breast lump workup

While breast lumps are common, deciding what to do when someone presents with one can be tricky...

MHT risks and progestogens

While the risks of unopposed oestrogen are widely acknowledged, important nuances can be missed...

MHT & bone health: how does it stack up?

MHT can be just as effective for preventing postmenopausal fracture as bone-specific medications—minus some of the risks.

Polycystic ovarian syndrome – Part 2: Clinical features

Dr Anju Joham & Dr Chau Thien (Jillian) Tay discuss the clinical features of PCOS diagnosis, inlcuding pregnancy and long-term health impacts.

Ryeqo approved for endometriosis

Ryeqo has been available in Australia since 2022, but until now was not specifically indicated for endometriosis. Here's how it works and what you need to be aware of.

Feminist narratives are being hijacked to market medical tests not backed by evidence

Corporations have used feminist language to promote their products for decades. In the 1980s, companies co-opted messaging about female autonomy to encourage women’s consumption of unhealthy commodities, such as tobacco and alcohol.

Polycystic ovarian syndrome – Part 1: Diagnosis

Dr Anju Joham & Dr Chau Thien (Jillian) Tay discuss the clinical features with PCOS diagnosis and how this may differ across the lifespan, and clarity regarding PCOS and pregnancy.

New vaginal atrophy treatment coming soon

Intrarosa was approved by the TGA last year and is expected to be available in Australia from mid-2024. Here's what you need to know...

Natural supplements for menopause – worth it or waste of money?

The market is awash with products claiming to be rooted in ancient traditions that have allegedly given women relief from menopausal symptoms - but how do the claims stack up?

Hot flushes and night sweats: non-hormonal pharmacological options

We look at the evidence for pharmaceutical agents beyond MHT...

Cervical cancer screening podcast series

Prof Deborah Bateson, Sexual Health Physician, and Dr Rebecca South, Women's Health GP, answer a series of questions on the topic of cervical cancer screening. These questions were compiled by GPs and health professionals across Australia.

Top podcasts of 2023

We’ve compiled all the popular podcasts your colleagues have been listening to in 2023.

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Women's health

While breast lumps are common, deciding what to do when someone presents with one can be tricky...

While the risks of unopposed oestrogen are widely acknowledged, important nuances can be missed...

MHT can be just as effective for preventing postmenopausal fracture as bone-specific medications—minus some of the risks.

Dr Anju Joham & Dr Chau Thien (Jillian) Tay discuss the clinical features of PCOS diagnosis, inlcuding pregnancy and long-term health impacts.

Ryeqo has been available in Australia since 2022, but until now was not specifically indicated for endometriosis. Here's how it works and what you need to be aware of.

Corporations have used feminist language to promote their products for decades. In the 1980s, companies co-opted messaging about female autonomy to encourage women’s consumption of unhealthy commodities, such as tobacco and alcohol.

Dr Anju Joham & Dr Chau Thien (Jillian) Tay discuss the clinical features with PCOS diagnosis and how this may differ across the lifespan, and clarity regarding PCOS and pregnancy.

Intrarosa was approved by the TGA last year and is expected to be available in Australia from mid-2024. Here's what you need to know...

The market is awash with products claiming to be rooted in ancient traditions that have allegedly given women relief from menopausal symptoms - but how do the claims stack up?

We look at the evidence for pharmaceutical agents beyond MHT...

Prof Deborah Bateson, Sexual Health Physician, and Dr Rebecca South, Women's Health GP, answer a series of questions on the topic of cervical cancer screening. These questions were compiled by GPs and health professionals across Australia.

We’ve compiled all the popular podcasts your colleagues have been listening to in 2023.

Get the app

Site

Company

Connect

Legal

LOG IN FOR FULL ACCESS

SIGN UP FOR A FREE HEALTHED ACCOUNT

Extra Details

PASSWORD RESET

Discover

Healthed